In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

The US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz), from US pharma major Eli Lilly, for the ...

As the Biden presidency winds down, the administration touted its Cancer Moonshot accomplishments, including regulatory action against forever chemicals and ethylene oxide, expanded access to cancer ...

USA News Group – How we deal with future spikes in disease cases and potential global pandemics is evolving rapidly. Not only is the World Economic Forum championing more ...

Berenberg analyst Kerry Holford lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,050 and keeps a Buy rating on the shares.

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...

BofA Securities analysts reaffirmed a Buy rating for Eli Lilly (NYSE:LLY) with a price target on the stock of $997. The company stands out as a premier opportunity within the large-cap biopharma ...

Gov. Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost of the ...

Life Time is set to break out to record highs on its preliminary Q4 results, 2025 outlook. Planet Fitness scored a breakout ...

Alphabet ( GOOG) ( GOOGL ), Philip Morris International ( PM) and Mastercard ( MA) were among the least shorted S&P 500 ( ...

Donald Trump's nominees for top national security jobs said they would not prioritize their loyalty to the president-elect over their duty to the country in U.S. Senate hearings on Wednesday ...